NYU Langone Health / NYU Grossman School of Medicine Apr 15 2025 Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the study showed that approximately 80% of stage III melanoma patients who had detectable levels of circulating tumor DNA (ctDNA) before they started treatment to suppress their tumors went on to experience recurrence. The

Tag-uri: DNA